Search | eNauka

Research outputs

Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study [2021]

Vinereanu, Dragos; Napalkov, Dmitry; Bergler-Klein, Jutta; Benczur, Bela; Ciernik, Martin; Gotcheva, Nina; Medvedchikov, Alexey; Poder, Pentti; Simić, Dragan V. ; Skride, Andris;

Tang, Wenbo; Trusz-Gluza, Maria; Vesely, Jiri;

The oncology treatment of patients who use oral anticoagulants is connected with high risk of bleeding complications [2010]

Kovac, Zeljko; Kovač, Mirjana ; Mitić, Gorana ; Antonijević, Nebojša

Human cytomegalovirus infection and atherothrombosis [2012]

Popović, Milan; Smiljanić, Katarina ; Dobutović, Branislava; Syrovets, Tatiana; Simmet, Thomas; Isenovic, Esma R.

Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha [2017]

Bećarević, Mirjana

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome [2008]

Perunicić, Jovan; Antonijević, Nebojša ; Miljić, Predrag ; Đorđević, Valentina ; Miković, Danijela; Kovač, Mirjana ; Đokić, Milan; Mrdović, Igor ; Nikolić, Aleksandra ; Vasiljević, Zorana

Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors [2010]

Popović, Milan; Paskas, Svetlana ; Živković, Maja ; Burysek, Ladislav; Laumonnier, Yves

Combined thrombophilic risk factors and essential thrombocythemia in patient with recurrent venous thromboembolic episodes - Thirty-three-year follow-up [2005]

Antonijević, Nebojša; Stanojević, M; Milosević, R; Đorđević, V ; Jauković, M; Vukcević, V; Kovač, Mirjana ; Miković, D; Radojković, Dragica ; Vasiljević, Z

Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study [2021]

The oncology treatment of patients who use oral anticoagulants is connected with high risk of bleeding complications [2010]

Human cytomegalovirus infection and atherothrombosis [2012]

Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha [2017]

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome [2008]

Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors [2010]

Combined thrombophilic risk factors and essential thrombocythemia in patient with recurrent venous thromboembolic episodes - Thirty-three-year follow-up [2005]

Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C91/3 genotypes [2011]

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population [2008]

Reticulated platelets and antiplatelet therapy response in diabetic patients [2015]

Филтери

Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study [2021]

The oncology treatment of patients who use oral anticoagulants is connected with high risk of bleeding complications [2010]

Human cytomegalovirus infection and atherothrombosis [2012]

Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha [2017]

Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome [2008]

Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors [2010]

Combined thrombophilic risk factors and essential thrombocythemia in patient with recurrent venous thromboembolic episodes - Thirty-three-year follow-up [2005]

Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C9*1/*3 genotypes [2011]

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population [2008]

Reticulated platelets and antiplatelet therapy response in diabetic patients [2015]

Филтери

Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C91/3 genotypes [2011]